Peter Verhamme
- Internal Medicine top 0.02%
- Venous Thromboembolism Diagnosis and Management 122
-
- Atrial Fibrillation Management and Outcomes 99
- Antiplatelet Therapy and Cardiovascular Diseases 29
- Blood Pressure and Hypertension Studies 23
- Cardiovascular Health and Disease Prevention 21
- Hematology top 0.5%
- Blood Coagulation and Thrombosis Mechanisms 41
- Platelet Disorders and Treatments 22
- Emergency Medical Services top 0.2%
- Genetics top 1%
-
- Antimicrobial Resistance in Staphylococcus 22
- Co-authors
- Jeffrey I. WeitzThomas VanasschePeter SinnaeveHein HeidbüchelJonas OldgrenMatthias AntzWerner HackeMarco Alings
- Journals
- Journal of Thrombosis and Haemostasis (29 papers)Thrombosis Research (20 papers)European Heart Journal (14 papers)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Peter Verhamme
336 papers receiving 12.8k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Internal Medicine 5.5k
- Cardiology and Cardiovascular Medicine 7.1k
- Hematology 1.7k
- Emergency Medical Services 712
- Genetics 736
Countries citing papers authored by Peter Verhamme
This map shows the geographic impact of Peter Verhamme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Verhamme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Verhamme more than expected).
Fields of papers citing papers by Peter Verhamme
This network shows the impact of papers produced by Peter Verhamme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Verhamme. The network helps show where Peter Verhamme may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Verhamme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 13 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 11 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 8 | |
| 12 | 2021 | 6 | |
| 13 | 2020 | 62 | |
| 14 | 2019 | 25 | |
| 15 | 2018 | 21 | |
| 16 | 2018 | 30 | |
| 17 | Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillationbreakdown → | 2015 | 745 |
| 18 | 2015 | 0 | |
| 19 | 2014 | 29 | |
| 20 | Placental growth factor increases regional myocardial blood flow and function in a new porcine model of chronic myocardial ischemia | 2009 | 1 |
About Peter Verhamme
Peter Verhamme is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology, having authored 350 papers that have together received 13.1k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (122 papers), Atrial Fibrillation Management and Outcomes (99 papers), Blood Coagulation and Thrombosis Mechanisms (41 papers), Antiplatelet Therapy and Cardiovascular Diseases (29 papers), Blood Pressure and Hypertension Studies (23 papers), Platelet Disorders and Treatments (22 papers), Antimicrobial Resistance in Staphylococcus (22 papers) and Cardiovascular Health and Disease Prevention (21 papers). The work is most often cited by research in Internal Medicine (5.5k citations), Cardiology and Cardiovascular Medicine (7.1k citations) and Hematology (1.7k citations). Peter Verhamme has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Jeffrey I. Weitz, Thomas Vanassche, Peter Sinnaeve, Hein Heidbüchel, Jonas Oldgren, Matthias Antz, Werner Hacke, Marco Alings, Marc Hoylaerts and Paulus Kirchhof. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Thrombosis Research, European Heart Journal, Blood and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.